VolitionRX Ltd (VNRX) Stock Overview
Explore VolitionRX Ltd’s financial performance, market position, analyst ratings, and future outlook.
VolitionRX Ltd (VNRX)
Key Financials
Key Financials
Market Cap
3.4M
P/E Ratio
-0.11
EPS (TTM)
$-3.87
ROE
0.77%
VNRX Stock Analysis & Investment Overview (AMEX)
Our AI-powered analysis of VolitionRX Ltd (AMEX: VNRX) gives investors deep insight into how the stock performs on the AMEX exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, VolitionRX Ltd's AMEX-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of VNRX on the AMEX shows an RSI of 17.27, suggesting the stock is in a an oversold condition. Our forecasting models predict a 12-month price target of $1.77 for the AMEX listing.
Key metrics behind VolitionRX Ltd's AMEX-traded stock include a P/E ratio of -0.11 and a market capitalization of 3.4M. Combined with our AI analysis, these give both institutional and retail investors a clear view of VNRX on the AMEX.